Delivery Order SPE2DB24D2205-SPE2DB25FEGNC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Viscoat Syringes (0.75mL) with a contract ceiling value of $21,251.96. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $2,628.99 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Viscoat syringes (0.5mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 18, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025, for the supply of Viscoat Syringes (0.5 mL). This firm fixed-price delivery order carries a ceiling value of $1,554.87 and is scheduled for completion by August 21, 2025. The contract utilizes no set-aside designation and represents a competitive award. The work will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Viscoat syringes (0.75ML) under a firm fixed-price contract valued at $21,916.13. The order was competitively awarded without set-aside designation and is scheduled for completion by August 6, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $14,627.79 delivery order to AmerisourceBergen Drug Corp for Viscoat syringes (0.5mL) on August 11, 2025, with a completion date of August 12, 2025. The contract employs firm fixed pricing and carries no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a $9,100.35 delivery order to AmerisourceBergen Drug Corp for VISCOAT syringes (0.5mL) on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle that runs through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $2,443.75 to AmerisourceBergen Drug Corp for 0.5mL Viscoat syringes, with an ultimate completion date of August 22, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office based in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,066.90 to AmerisourceBergen Drug Corp for the supply of Viscoat syringes in 0.5ML configuration. This competitive, non-set-aside contract operates under a firm fixed price structure with an ultimate completion date of July 30, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued as a child contract under...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a delivery order worth $4,083.45 for the supply of Viscoat Syringes 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 21, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 0.5 mL VISCOAT syringes. The $5,065.40 firm-fixed-price contract has a completion date of May 15, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGNCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Viscoat Syringes (0.5 mL) under a firm fixed-price contract valued at $3,452.31. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 21, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a critical vendor for federal medical procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a broad range of medical products and pharmaceuticals to support military healthcare programs and other federal medical systems worldwide. The company's consistent receipt of competitive awards and its substantial prime vendor contract reflect its capability to meet the Defense Logistics Agency's requirements for reliable medical supply delivery across multiple therapeutic domains and medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 8/20/25 |